Article
Evry, France—Novagali Pharma, a drug delivery specialty company using cationic emulsions to develop age-related macular degeneration treatments, has hired Florence Barouki-Binlich, MD, as its vice president for development and medical affairs.
Evry, France-Novagali Pharma, a drug delivery specialty company using cationic emulsions to develop age-related macular degeneration treatments, has hired Florence Barouki-Binlich, MD, as its vice president for development and medical affairs.
Dr. Barouki-Binlich will be responsible for all stages of pharmaceutical development, including regulatory affairs, preclinical and clinical research, finding investigators, and analyzing results. Her appointment comes as the company prepares to launch preclinical and clinical trials in ophthalmology (cyclosporine formulations) and oncology.
She most recently spent 4 years at Bayer Pharma (France), where she headed the company's Therapeutic Group.
Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies
Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery